Key facts
| Price (PPV) | 34.20 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amoxicillineacide clavulanique |
| Class | Antibacterials for systemic use |
| ATC code | J01CR02 |
| Manufacturer | BOTTU S.A. |
| Presentation | Flaccon de 30 ml |
| Nature | Médicament |
| Hospital price | 21.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Indiqué pour le traitement des infections suivantes chez les adultes et les enfants: - sinusite bactérienne aiguë (diagnostiquée de façon appropriée), - otite moyenne aiguë, - exacerbations aiguës de bronchite chronique (diagnostiquée de façon appropriée), - pneumonie aiguë communautaire, - cystite, - pyélonéphrite, - infections de la peau et des tissus mous, en particulier cellulite, morsures animales, abcès dentaire sévère avec propagation de cellulite, - infections des os et des articulations, en particulier ostéomyélite. Il convient de tenir compte des recommandations officielles concernant l’utilisation appropriée des antibactériens.
Find an open pharmacy
On-call pharmacies near you
About Zamox 100 mg / 12.5 mg
Zamox 100 mg / 12.5 mg belongs to the antibacterials for systemic use therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Zamox 100 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Zamox 100 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.